Who Owns Fortress Biotech Stock?
NASDAQ: FBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 31.40%
- Held by insiders
- 23.90%
- Institutional holders
- 69
- Institutions 31.4%
- Insiders 23.9%
- Public and other 44.7%
Who owns Fortress Biotech stock?
Institutional investors own about 31.4% of Fortress Biotech's shares, spread across 69 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 23.90% of FBIO.
The largest institutional holders are Vanguard Capital Management LLC (3.11%), Opaleye Management Inc. (2.67%) and Mackenzie Financial Corporation (1.67%). Together, the top 10 institutions control 13.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their FBIO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FBIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.04M | 3.11% | +7.4% |
| Opaleye Management Inc. | 890.00K | 2.67% | -14.6% |
| Mackenzie Financial Corporation | 555.68K | 1.67% | +100.0% |
| GSA Capital Partners LLP | 458.47K | 1.37% | +80.4% |
| Shikiar Asset Management, Inc. | 305.47K | 0.92% | 0.0% |
| Geode Capital Management, LLC | 300.52K | 0.90% | +3.5% |
| Blackrock Inc. | 224.78K | 0.67% | +14.1% |
| Two Sigma Investments, LP | 213.79K | 0.64% | +8.6% |
| Bridgeway Capital Management, LLC | 177.37K | 0.53% | -2.7% |
| Vanguard Fiduciary Trust Co | 166.37K | 0.50% | +16.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FBIO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 697.80K | 2.09% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 279.89K | 0.84% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 152.37K | 0.46% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 143.18K | 0.43% |
| iShares Trust-iShares Micro-Cap ETF | 87.56K | 0.26% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 49.32K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 35.87K | 0.11% |
| EA Series Trust-EA Bridgeway Omni Small-Cap Value ETF | 25.00K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 18.55K | 0.06% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 18.05K | 0.05% |
Frequently asked questions
Who is the largest shareholder of Fortress Biotech?
Vanguard Capital Management LLC is the largest institutional shareholder of FBIO, owning 3.11% of shares outstanding (1.04M shares) as of its latest 13F filing.
What percentage of Fortress Biotech is owned by institutions?
Institutions own about 31.4% of FBIO shares and 41.3% of the public float.
How much of Fortress Biotech do insiders own?
Insiders, such as officers and directors, own about 23.90% of FBIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.